/MXDHF

MXDHF Stock - MDxHealth S.A.

Q: What is the analyst price target for MXDHF?

Analyst price target information is not currently available for MXDHF.

Q: What is MXDHF's market cap?

Market capitalization information is not currently available for MXDHF.

Healthcare|Medical - Diagnostics & Research|OTC

$0.25-9.09%

$0.03 (-9.09%) • Oct 17

GoAI Score

Weighted average: Momentum (25%) + Sentiment (35%) + Risk (20%) + Value (20%). ≥70 = BUY, ≤35 = SELL.

HOLD

Medium Confidence

Momentum

Momentum Score

Based on price vs 50-day MA (40%), 200-day MA (40%), and MA crossover (20%). Higher = stronger uptrend.

Sentiment

Sentiment Score

Based on analyst price target upside. 50 = neutral, 100 = very bullish (25%+ upside expected).

Risk Score

Based on stock beta (volatility). Higher score = lower risk. Red (<40) = high volatility, Green (>60) = stable.

Price Target

Average analyst price target from the last quarter. Shows expected upside/downside from current price.

+10.0%upside

Target: $0.28

AI Analysis PreviewPremium

Real-time AI-powered market analysis

Precise entry/exit price targets

Risk assessment & position sizing

Unlock GoAI Insights for MXDHF

Get institutional-grade AI analysis, real-time signals, and deep market intelligence powered by advanced machine learning.

Buy/Sell Signals

94% win rate on Alpha signals

Deep Analysis

Institutional-grade thesis

Real-Time Alerts

SMS & push notifications

Risk Scoring

Multi-factor analysis

Free 14-day trial • No credit card required

Financial Statements

Revenue & Profitability Trend

FY2020

FY2021

FY2022

FY2023

FY2024

← Swipe to see more →

Revenue

Net Income (Profit)

Net Loss

Key Metrics

Market CapN/A

P/E RatioN/A

Beta0.73

52W High$0.65

52W Low$0.00

Avg VolumeN/A

Income Statement (Fiscal Year)

Metric	FY2024	FY2023	FY2022	FY2021	FY2020
Revenue	$90.05M	$70.19M	$37.05M	$22.24M	$18.46M
Gross Profit	$55.14M	$43.93M	$19.22M	$10.56M	$8.04M
Gross Margin	61.2%	62.6%	51.9%	47.5%	43.6%
Operating Income	$-24,722,000	$-27,327,000	$-37,900,000	$-26,841,000	$-27,123,000
Net Income	$-38,069,000	$-43,100,000	$-44,044,000	$-29,002,000	$-28,662,000
Net Margin	-42.3%	-61.4%	-118.9%	-130.4%	-155.3%
EPS	$-0.78	$-1.66	$-2.78	$-2.38	$-3.44

Company Overview

MDxHealth SA, a commercial-stage precision diagnostics company, provides urologic solutions in the United States, the Netherlands, Belgium, Spain, Poland, Italy, rest of European Union, and internationally. Its novel prostate cancer genomic testing solutions are SelectMDx, a non-invasive urine test; and ConfirmMDx, an epigenetic test, which provide physicians with a clinical pathway to identify clinically prostate cancer while minimizing the use of invasive procedures that are prone to complications. The company was formerly known as OncoMethylome Sciences SA and changed its name to MDxHealth SA in October 2010. MDxHealth SA was incorporated in 2003 and is headquartered in Herstal, Belgium.

Visit Website

Earnings History & Surprises

MXDHF

Beat Rate

Last 0 quarters

Avg Surprise

+0%

EPS vs Estimate

Beats / Misses

0/0

Last 12 quarters

Latest EPS

$-0.04

Q3 2023

EPS Surprise History

Q3 23

No data

Beat Estimate

Missed Estimate

Quarterly EPS Details

Period	Report Date	Estimated EPS	Actual EPS	Surprise	Result
Q3 2023	Sep 30, 2023	—	$-0.04	—	—

Frequently Asked Questions about MXDHF

What is MXDHF's current stock price?

MDxHealth S.A. (MXDHF) is currently trading at $0.25 per share. The stock has moved -9.09% today.

What is the analyst price target for MXDHF?

No analyst price targets are currently available for this stock.

What sector is MDxHealth S.A. in?

MDxHealth S.A. operates in the Healthcare sector, specifically within the Medical - Diagnostics & Research industry. The company is traded on the OTC exchange.

What is MXDHF's market cap?

MDxHealth S.A. has a market capitalization of $0.01 billion, making it a small-cap company.

Does MXDHF pay dividends?

No, MDxHealth S.A. does not currently pay a dividend to shareholders.